These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3580004)

  • 41. Cyclophosphamide, 2,2-dimethylaziridines and other alkylating agents as inhibitors of serum cholinesterase.
    Lalka D; Bardos TJ
    Biochem Pharmacol; 1975 Feb; 24(4):455-6. PubMed ID: 1167458
    [No Abstract]   [Full Text] [Related]  

  • 42. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives: part IV. Mechanism and kinetics of specific acid-catalyzed hydrolysis of sulfadimidine.
    Zajac M
    Pol J Pharmacol Pharm; 1977; 29(5):555-63. PubMed ID: 22848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1-Bromopinacolone, an active site-directed covalent inhibitor for acetylcholinesterase.
    Cohen SG; Lieberman DL; Hasan FB; Cohen JB
    J Biol Chem; 1982 Dec; 257(23):14087-92. PubMed ID: 7142196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific labelling of the curare binding sites of acetylcholinesterase and some properties of the modified enzyme.
    Belleau B; DiTullio V
    Can J Biochem; 1971 Oct; 49(10):1131-3. PubMed ID: 5168943
    [No Abstract]   [Full Text] [Related]  

  • 45. 31P NMR investigations of phosphoramide mustard: evaluation of pH control over the rate of intramolecular cyclization to an aziridinium ion and the hydrolysis of this reactive alkylator.
    Engle TW; Zon G; Egan W
    J Med Chem; 1979 Aug; 22(8):897-9. PubMed ID: 40026
    [No Abstract]   [Full Text] [Related]  

  • 46. Microcalorimetric determination of binding sites of acetylcholinesterase.
    Das YT; Brown HD; Chattopadhyay SK
    Biochim Biophys Acta; 1983 May; 745(1):107-10. PubMed ID: 6849937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetic evidence for the allosteric substrate inhibition of human erythrocyte acetylcholinesterase.
    Niday E; Wang CS; Alaupovic P
    Biochim Biophys Acta; 1980 Mar; 612(1):67-72. PubMed ID: 7362833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modification of acetylcholinesterase with N-dansylaziridine.
    Mutus B; Tomlinson G; Duncan DV
    Biochem Biophys Res Commun; 1981 Oct; 102(4):1136-43. PubMed ID: 7317044
    [No Abstract]   [Full Text] [Related]  

  • 49. Anionic subsites of the acetylcholinesterase from Torpedo californica: affinity labelling with the cationic reagent N,N-dimethyl-2-phenyl-aziridinium.
    Weise C; Kreienkamp HJ; Raba R; Pedak A; Aaviksaar A; Hucho F
    EMBO J; 1990 Dec; 9(12):3885-8. PubMed ID: 2249655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The slow rate of inhibition of acetylcholinesterase by fluoride.
    Froede HC; Wilson IB
    Mol Pharmacol; 1985 Jun; 27(6):630-3. PubMed ID: 4000107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetylcholinesterase. Two types of inhibition by an organophosphorus compound: one the formation of phosphorylated enzyme and the other analogous to inhibition by substrate.
    Aldridge WN; Reiner E
    Biochem J; 1969 Nov; 115(2):147-62. PubMed ID: 5378376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of acetylthiocholine binding to electric eel acetylcholinesterase in glycerol/water solvents of increased viscosity. Evidence for a diffusion-controlled reaction.
    Hasinoff BB
    Biochim Biophys Acta; 1982 May; 704(1):52-8. PubMed ID: 7093289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemical mechanism of the radiation potentiating effects of 2,2-dimethylaziridine-type antitumor agents.
    Bardos TJ; Dunn JA; Perlman ME
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1653-6. PubMed ID: 536272
    [No Abstract]   [Full Text] [Related]  

  • 54. Modification of acetylcholinesterase with the fluorescent thiol reagent S-mercuric-N-dansylcysteine.
    Mutus B; Duncan DV; Tomlinson G
    Biochem Biophys Res Commun; 1983 May; 112(3):941-7. PubMed ID: 6847689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bovine serum albumin as a catalyst. VI. Specificity of several nucleophilic groups in the protein for N-dansylaziridine.
    Sturgill TW; Baskin GS; Taylor RP
    Biochim Biophys Acta; 1977 Nov; 485(1):236-41. PubMed ID: 911863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formation of an unstable covalent intermediate during the inhibition of electric-eel acetylcholinesterase with 1,3,2-dioxaphosphorinane 2-oxides.
    Ashani Y; Leader H
    Biochem J; 1979 Mar; 177(3):781-90. PubMed ID: 444203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions between acetylcholinesterase and tetra-N-alkylammonium ions.
    Sellers DJ; Watts P; Wilkinson RG
    Biochem Pharmacol; 1983 Mar; 32(5):787-93. PubMed ID: 6838627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of fumarase by S-2,3-dicarboxyaziridine.
    Greenhut J; Umezawa H; Rudolph FB
    J Biol Chem; 1985 Jun; 260(11):6684-6. PubMed ID: 3997845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of acetylcholinesterase immobilized on polyethylene tubing.
    Ngo TT; Laidler KJ; Yam CF
    Can J Biochem; 1979 Oct; 57(10):1200-3. PubMed ID: 540236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Aryl esters of N-diethylenediamidophosphonyl-2-vinylcarbamic acid].
    Trokhymenko IS
    Farm Zh; 1980; (2):71-2. PubMed ID: 7389885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.